Emergent Biosolutions received a contract modification from the Office of the Assistant Secretary for Preparedness and Response (ASPR) valued at $99.9 million to supply ACAM2000 vaccine to the U.S. Strategic National Stockpile. They also received a contract modification from ASPR valued at $30.0 million to procure additional doses of CYFENDUS vaccine.